Form 4 for XERS Xeris Biopharma Holdings, Inc.
Accepted 2025-09-15 00:00:00 ET · period of report 2025-09-11 · accession 0002031695-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-09-15 | 2025-09-11 | XERS | McCulloch Kevin | See Remarks | J - Other | $0.00 | -2,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | J | D | 2,000 | $0.00 | 0 | I By Charles R. McCulloch Trust dated 1990 | — | — |